Range
67.7 - 68.39
Vol / Avg.
4.9M/6.2M
Div / Yield
2.84/4.20%
52 Wk
56.56 - 73.34
Mkt Cap
84.9B
Payout Ratio
67.8
Open
67.97
P/E
16.5
EPS
1.21
Shares
1.3B
Outstanding
1.3B
Total Float
1.3B
load more
Sector: Health Care.Industry: Biotechnology
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS1.730

(EXPECTED) 2021-10-28

REV6.240B
Q2 2021Est.ActualSurprise
EPS1.7301.870 0.1400
REV6.070B6.217B147.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Gilead Sciences Questions & Anwsers

Q

How do I buy Gilead Sciences (GILD) stock?

A

You can purchase shares of Gilead Sciences (NASDAQ: GILD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Gilead Sciences's (GILD) competitors?

Q

What is the target price for Gilead Sciences (GILD) stock?

A

The latest price target for Gilead Sciences (NASDAQ: GILD) was reported by Morgan Stanley on October 12, 2021. The analyst firm set a price target for 84.00 expecting GILD to rise to within 12 months (a possible 24.02% upside). 21 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Gilead Sciences (GILD)?

A

The stock price for Gilead Sciences (NASDAQ: GILD) is $67.73 last updated Tue Oct 26 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Gilead Sciences (GILD) pay a dividend?

A

There are no upcoming dividends for Gilead Sciences. The last dividend paid out to investors was $0.04 on September 14, 2021.

Q

When is Gilead Sciences (NASDAQ:GILD) reporting earnings?

A

Gilead Sciences’s $Q3 earnings are confirmed for after-market on $October 28, 2021.

Q

Is Gilead Sciences (GILD) going to split?

A

There is no upcoming split for Gilead Sciences.

Q

What sector and industry does Gilead Sciences (GILD) operate in?

A

Gilead Sciences is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.